Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer

ABSTRACT: A multicenter, randomized, open-label, three-period, and reference-replicated crossover study was conducted in 48 patients with colorectal or breast cancer under fed conditions to assess the bioequivalence between two formulations of capecitabine.

DISEASE(S): Patient Participation

PROVIDER: 2341726 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR